Raymond Debbane - 25 Feb 2026 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Raymond Debbane
Issuer symbol
LXRX
Transactions as of
25 Feb 2026
Net transactions value
+$2,980
Form type
4
Filing time
27 Feb 2026, 08:33:21 UTC
Previous filing
25 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DEBBANE RAYMOND Director 2445 TECHNOLOGY FOREST BLVD., 11TH FLOOR, THE WOODLANDS /s/ Raymond Debbane 27 Feb 2026 0001053890

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Purchase $2,980 +2,000 +0.11% $1.49 1,906,186 25 Feb 2026 Direct
holding LXRX Common Stock 1,538,462 25 Feb 2026 By Avicenna Life Sci Master Fund LP and related parties
holding LXRX Common Stock 7,362,368 25 Feb 2026 By Invus Public Equities, L.P. and related parties
holding LXRX Common Stock 5,451,204 25 Feb 2026 By Invus US Partners, LLC and related parties
holding LXRX Common Stock 35,402,689 25 Feb 2026 By Invus, L.P. and related parties
* An asterisk sign (*) next to the price indicates that the price is likely invalid.